Bio-Quant Announces the Expansion of Its Research Animal Diagnostic Services to Cover All Nine Species.SAN DIEGO -- Bio-Quant, Inc. ("Bio-Quant") (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). : BQNT.PK), the largest biotech Contract Research Organization (CRO) in San Diego, announced today the expansion of its animal diagnostic services diagnostic services, n.pl the imaging and laboratory capabilities available for determining the cause of an illness. division to cover all nine species used in research. Dr. Bassam Damaj, Chief Executive Officer of Bio-Quant, said, "Animal welfare is of great importance, and Bio-Quant is very pleased to announce the expansion of its Research Animal Diagnostic Services. Bio-Quant is the only local facility providing this high quality service to the San Diego community, and we will continue to grow our capabilities in this area to support our client's needs. This marks the completion of our planned expansion program that we have been implementing over the last couple of years." He added, "Our laboratory covers comprehensive clinical chemistry, hematology, coagulation coagulation (kōăg'y  lā`shən), the collecting into a mass of minute particles of a solid dispersed throughout a liquid (a sol), usually followed by the precipitation or , blood gas analysis, urine analysis
for all nine species. The advanced equipment used at Bio-Quant allows
the analysis of full CBC (1) (Cell Broadcast Center) See cell broadcast.(2) (Cipher Block Chaining) In cryptography, a mode of operation that combines the ciphertext of one block with the plaintext of the next block. with only 15uL of blood as opposed to the 100uL required by most laboratories allowing researchers to run multiple CBCs during their experimental studies without affecting the health status of the animals." Other specialty services are also provided worldwide by Bio-Quant such as Elisa, FACS FACS Fellow of the American College of Surgeons. FACS abbr. Fellow of the American College of Surgeons FACS fluorescence-activated cell sorter. analysis, protein electrophoresis Protein Electrophoresis Definition Electrophoresis is a technique used to separate different elements (fractions) of a blood sample into individual components. , and gel electrophoresis as well as in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. cellular functional assays. About Bio-Quant, Inc. Bio-Quant, Inc. is a profitable revenue-generating biotechnology pre-clinical contract research organization specializing in in vitro and in vivo pharmacology, PK and toxicology to support non-GLP pre-IND enabling studies in addition to vivarium housing services. The company is based in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation). San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951. with 20,000 sq ft office and laboratory facilities. The company specializes in pre-clinical work in the areas of Inflammation, Oncology, and Immunology, PK and toxicology services. More information is available at www.bio-quant.com When used anywhere in this document, the words "expects", "believes", "anticipates", "estimates" and similar expressions are intended to identify forward-looking statements. Forward-looking statements herein may include statements addressing future financial and operating results of Bio-Quant and the timing, benefits and other aspects of the proposed merger. Bio-Quant has based these forward-looking statements on its current expectations about future events. Such statements are subject to risks and uncertainties including, but not limited to, the successful implementation of Bio-Quant's strategic plans, the acceptance of new products, the obsolescence ob·so·les·cent adj. 1. Being in the process of passing out of use or usefulness; becoming obsolete. 2. Biology Gradually disappearing; imperfectly or only slightly developed. of existing products, the resolution of existing and potential future patent issues. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Bio-Quant disclaims any undertaking to publicly update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion